Showing results (391-400 of 592) with videos related to
Sort By:
Pageof 60
Applied Immunohistochemistry & Molecular Morphology : AIMM|October 19, 2016
Pulmonary Adenocarcinoma With Enteric Differentiation: Immunohistochemistry and Molecular MorphologyAlessia Nottegar, Fabrizio Tabbò, Claudio Luchini, et al.Frontiers in Oncology|May 3, 2021
Large Cell Neuro-Endocrine Carcinoma of the Lung: Current Treatment Options and Potential Future OpportunitiesMiriam Grazia Ferrara, Alessio Stefani, Michele Simbolo, et al.Journal of Thoracic Disease|November 18, 2024
Artificial intelligence applications in personalizing lung cancer management: state of the art and future perspectivesFilippo Lococo, Galal Ghaly, Sara Flamini, et al.Cancers|June 26, 2026
From Clinical Trials to Real-World Practice: Surgical Feasibility and Postoperative Outcomes After Neoadjuvant Chemoimmunotherapy for Locally Advanced NSCLC in a Single-Center ExperienceFilippo Lococo, Dania Nachira, Khrystyna Kuzmych, et al.Breast (Edinburgh, Scotland)|July 11, 2016
Prognostic model for advanced breast carcinoma with luminal subtype and impact of hormonal maintenance: Implications for post-progression and conditional survivalLuisa Carbognin, Isabella Sperduti, Mariangela Ciccarese, et al.Human Vaccines & Immunotherapeutics|March 8, 2022
Circulating immune profile can predict survival of metastatic uveal melanoma patients: results of an exploratory studyErnesto Rossi, Ilaria Grazia Zizzari, Alessandra Di Filippo, et al.Breast (Edinburgh, Scotland)|March 7, 2013
Gene expression profiling in breast cancer: a clinical perspectiveGrazia Arpino, Daniele Generali, Anna Sapino, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 5, 2014
Double-blind, placebo-controlled, multicenter, randomized, phase IIb neoadjuvant study of letrozole-lapatinib in postmenopausal hormone receptor-positive, human epidermal growth factor receptor 2-negative, operable breast cancerValentina Guarneri, Daniele Giulio Generali, Antonio Frassoldati, et al.The Oncologist|November 15, 2017
First Prospective Multicenter Italian Study on the Impact of the 21-Gene Recurrence Score in Adjuvant Clinical Decisions for Patients with ER Positive/HER2 Negative Breast CancerMaria Vittoria Dieci, Valentina Guarneri, Tommaso Giarratano, et al.Translational Lung Cancer Research|February 11, 2021
Role of next generation sequencing-based liquid biopsy in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: impact of STK11, KRAS and TP53 mutations and co-mutations on outcomeAlberto Pavan, Andrea Boscolo Bragadin, Lorenzo Calvetti, et al.Pageof 60